Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Liposomes market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Liposomesmarket, defines the market attractiveness level of Liposomes market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Liposomes industry, describes the types of Liposomes market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liposomes market and the development prospects and opportunities of Liposomes industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liposomes market in Chapter 13.
By Player:
Teva Pharmaceutical
Gilead Sciences
CSPC
Sun Pharmaceutical
Fudan-Zhangjiang
Pacira
Spectrum Pharmaceuticals
Kingond Pharm
Johnson & Johnson
Shanghai New Asia
Sigma-Tau Group
Luye Pharma
Novartis
By Type:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
By End-User:
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Liposomes Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Liposomes Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Liposomes Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Liposomes Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Liposomes Market Analysis and Outlook to 2022
-
7.1 Global Liposomes Consumption (2017-2022)
-
7.2 United States Liposomes Consumption (2017-2022)
-
7.3 Europe Liposomes Consumption (2017-2022)
-
7.4 China Liposomes Consumption (2017-2022)
-
7.5 Japan Liposomes Consumption (2017-2022)
-
7.6 India Liposomes Consumption (2017-2022)
-
7.7 South Korea Liposomes Consumption (2017-2022)
8 Region and Country-wise Liposomes Market Analysis and Outlook to 2028
-
8.1 Global Liposomes Consumption Forecast (2022-2028)
-
8.2 United States Liposomes Consumption Forecast (2022-2028)
-
8.3 Europe Liposomes Consumption Forecast (2022-2028)
-
8.4 China Liposomes Consumption Forecast (2022-2028)
-
8.5 Japan Liposomes Consumption Forecast (2022-2028)
-
8.6 India Liposomes Consumption Forecast (2022-2028)
-
8.7 South Korea Liposomes Consumption Forecast (2022-2028)
9 Global Liposomes Market Outlook by Types and Applications to 2022
-
9.1 Global Liposomes Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Liposomes Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Liposomes Market Outlook by Types and Applications to 2028
-
10.1 Global Liposomes Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Liposomes Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Liposomes Import and Export Analysis (Top 5 Countries)
-
11.1 Global Liposomes Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Liposomes Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Liposomes Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Liposomes Market Competitive Analysis
-
14.1 Teva Pharmaceutical
-
14.1.1 Teva Pharmaceutical Company Details
-
14.1.2 Teva Pharmaceutical Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva Pharmaceutical Liposomes Product and Service
-
14.2 Gilead Sciences
-
14.2.1 Gilead Sciences Company Details
-
14.2.2 Gilead Sciences Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Sciences Liposomes Product and Service
-
14.3 CSPC
-
14.3.1 CSPC Company Details
-
14.3.2 CSPC Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CSPC Liposomes Product and Service
-
14.4 Sun Pharmaceutical
-
14.4.1 Sun Pharmaceutical Company Details
-
14.4.2 Sun Pharmaceutical Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sun Pharmaceutical Liposomes Product and Service
-
14.5 Fudan-Zhangjiang
-
14.5.1 Fudan-Zhangjiang Company Details
-
14.5.2 Fudan-Zhangjiang Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Fudan-Zhangjiang Liposomes Product and Service
-
14.6 Pacira
-
14.6.1 Pacira Company Details
-
14.6.2 Pacira Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pacira Liposomes Product and Service
-
14.7 Spectrum Pharmaceuticals
-
14.7.1 Spectrum Pharmaceuticals Company Details
-
14.7.2 Spectrum Pharmaceuticals Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Spectrum Pharmaceuticals Liposomes Product and Service
-
14.8 Kingond Pharm
-
14.8.1 Kingond Pharm Company Details
-
14.8.2 Kingond Pharm Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Kingond Pharm Liposomes Product and Service
-
14.9 Johnson & Johnson
-
14.9.1 Johnson & Johnson Company Details
-
14.9.2 Johnson & Johnson Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Liposomes Product and Service
-
14.10 Shanghai New Asia
-
14.10.1 Shanghai New Asia Company Details
-
14.10.2 Shanghai New Asia Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shanghai New Asia Liposomes Product and Service
-
14.11 Sigma-Tau Group
-
14.11.1 Sigma-Tau Group Company Details
-
14.11.2 Sigma-Tau Group Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sigma-Tau Group Liposomes Product and Service
-
14.12 Luye Pharma
-
14.12.1 Luye Pharma Company Details
-
14.12.2 Luye Pharma Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Luye Pharma Liposomes Product and Service
-
14.13 Novartis
-
14.13.1 Novartis Company Details
-
14.13.2 Novartis Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novartis Liposomes Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Liposomes
-
Figure Liposomes Picture
-
Table Global Liposomes Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomes Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Liposomes Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Liposomes Consumption by Country (2017-2022)
-
Figure United States Liposomes Consumption and Growth Rate (2017-2022)
-
Table Europe Liposomes Consumption and Growth Rate (2017-2022)
-
Figure China Liposomes Consumption and Growth Rate (2017-2022)
-
Figure Japan Liposomes Consumption and Growth Rate (2017-2022)
-
Figure India Liposomes Consumption and Growth Rate (2017-2022)
-
Figure South Korea Liposomes Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomes Consumption Forecast by Country (2022-2028)
-
Figure United States Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Liposomes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Liposomes Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Liposomes Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Liposomes Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Liposomes Product and Service
-
Table CSPC (Foundation Year, Company Profile and etc.)
-
Table CSPC Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSPC Liposomes Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Liposomes Product and Service
-
Table Fudan-Zhangjiang (Foundation Year, Company Profile and etc.)
-
Table Fudan-Zhangjiang Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fudan-Zhangjiang Liposomes Product and Service
-
Table Pacira (Foundation Year, Company Profile and etc.)
-
Table Pacira Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pacira Liposomes Product and Service
-
Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Liposomes Product and Service
-
Table Kingond Pharm (Foundation Year, Company Profile and etc.)
-
Table Kingond Pharm Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kingond Pharm Liposomes Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Liposomes Product and Service
-
Table Shanghai New Asia (Foundation Year, Company Profile and etc.)
-
Table Shanghai New Asia Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai New Asia Liposomes Product and Service
-
Table Sigma-Tau Group (Foundation Year, Company Profile and etc.)
-
Table Sigma-Tau Group Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma-Tau Group Liposomes Product and Service
-
Table Luye Pharma (Foundation Year, Company Profile and etc.)
-
Table Luye Pharma Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luye Pharma Liposomes Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Liposomes Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Liposomes Product and Service
-
